The French startup Bioptimus is developing an artificial intelligence model to understand the different scales of life, from molecules to patients. Its first model, H-optimus-0, released as open-source, analyzes cancer tissue images to improve diagnostics and predict treatments. Bioptimus aims to create a knowledge engine capable of capturing the essence of biology and improving global health by collaborating with players in the pharmaceutical and biotech industries.
A French startup is building an AI trained on all of biology to speed up drug discovery
Help us improve this article
- Add a clear point? Share it in comment.
- Spot an error? Provide the correction and source.
- Broken link? Share a working alternative.
Your feedback helps keep the content accurate and valuable.
